Summary What is already known about this topic?Although a third coronavirus disease 2019(COVID-19)vaccination(booster)dose is highly recommended for diabetic patients,the vaccination behaviors and related adverse even...Summary What is already known about this topic?Although a third coronavirus disease 2019(COVID-19)vaccination(booster)dose is highly recommended for diabetic patients,the vaccination behaviors and related adverse events are unclear among diabetic patients with a COVID-19 booster dose.What is added by this report?Diabetic patients with higher postprandial blood glucose,worrying about the safety of the booster dose were less likely to get the vaccine.展开更多
Summary What is already known about this topic?Cancer patients are more vulnerable and have higher mortality rates from severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)than the general population;however,co...Summary What is already known about this topic?Cancer patients are more vulnerable and have higher mortality rates from severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)than the general population;however,coverage for booster doses of the coronavirus disease 2019(COVID-19)vaccine was low among cancer patients in China.What is added by this report?Overall,32.0%and 56.4%of cancer patients from four Provincial Level Administrative Divisions(PLADs)expressed hesitancy toward the first and second booster doses,respectively.Factors negatively associated with hesitancy to receive booster doses included positive attitudes,perceived support,and higher exposure to COVID-19 vaccination information.Conversely,postvaccination fatigue was positively associated with vaccine hesitancy.What are the implications for public health practice?Improved COVID-19 vaccination coverage is needed to promote health for cancer patients.展开更多
基金Supported by National Natural Science Foundation of China(81872674),and Four“Batches”Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province(2022XM45).
文摘Summary What is already known about this topic?Although a third coronavirus disease 2019(COVID-19)vaccination(booster)dose is highly recommended for diabetic patients,the vaccination behaviors and related adverse events are unclear among diabetic patients with a COVID-19 booster dose.What is added by this report?Diabetic patients with higher postprandial blood glucose,worrying about the safety of the booster dose were less likely to get the vaccine.
基金This study was supported by the National Natural Science Foundation of China(81872674)the Joint Foundation of Innovative Environment Construction of Autonomous Region of Xinjiang(#2019D01C326)+2 种基金the Four“Batches”Innovation Project of Invigorating Medical Cause through Science and Technology of Shanxi Province(2022XM45)Shenzhen Science and Technology Innovation Committee Projects(No.JCYJ20220818102817038)the Scientific Research Foundation of Peking University Shenzhen Hospital(No.KYQD2022216).
文摘Summary What is already known about this topic?Cancer patients are more vulnerable and have higher mortality rates from severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)than the general population;however,coverage for booster doses of the coronavirus disease 2019(COVID-19)vaccine was low among cancer patients in China.What is added by this report?Overall,32.0%and 56.4%of cancer patients from four Provincial Level Administrative Divisions(PLADs)expressed hesitancy toward the first and second booster doses,respectively.Factors negatively associated with hesitancy to receive booster doses included positive attitudes,perceived support,and higher exposure to COVID-19 vaccination information.Conversely,postvaccination fatigue was positively associated with vaccine hesitancy.What are the implications for public health practice?Improved COVID-19 vaccination coverage is needed to promote health for cancer patients.
